COVID-19: Resources for Practices Treating Patients with Substance Use Disorders (SUDs)

As the coronavirus pandemic is rapidly changing, practices are encouraged to check the CDC’s COVID-19 website and SAMHSA’s Current Topics for new information and resources related to COVID-19. 

The National Institute on Drug Abuse has issued a clinician advisory that some populations with SUDs may be impacted particularly hard by the novel coronavirus disease. The below resources have been gathered by the OklahomaMAT project team to provide relevant resources describing emergent policy changes and considerations for your patients’ behavioral health needs and continuation of MAT services for your patients.


42-CFR Part 2 and HIPAA

Patient Resources and Potential Challenges for SUD Patients During the Health Emergency

Recovery Support: Connecting to Virtual Meetings

  • Shatterproof suggests that  In The Rooms as a great place to find a virtual meeting. Shatterproof posted this infographic from the Recovery Research Institute for additional help in connecting to a virtual recovery support meeting.

Resilience and Coping

  • Shatterproof also posted this blog post shared by a person in long term recovery regarding coping strategies for dealing with changes in social activities that come with social distancing.

Accessing Behavioral Health and Other Psychosocial Services

SAMHSA Patient Materials on Stress and Coping

AIR Resources

  • The American Institutes for Research (AIR) has published a plain language summary of COVID-19 that can be shared with patients to help enhance their understanding of the current pandemic. 

Harm Reduction

The Harm Reduction Coalition shared these resources, developed for harm reduction programs and patients who use drugs regarding drug use and COVID-19.

Additional Provider Resources on COVID-19 and MAT

While some of these recommendations are specific to the state of California, the California Bridges to Treatment program offers many regularly updated features and resources related to MAT in the COVID-19 era.